echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > Advances in research on liquid tumor biopsy from Suzhou Institute of Nanotechnology, Chinese Academy of Sciences

    Advances in research on liquid tumor biopsy from Suzhou Institute of Nanotechnology, Chinese Academy of Sciences

    • Last Update: 2021-08-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Recently, Pei Renjun, a researcher at the Suzhou Institute of Nanotechnology and Nano-Bionics, Chinese Academy of Sciences, led a research team to use the coordination of tannic acid (TA) with iron ions to prepare functionalized ferroferric oxide magnetic nanoparticles, and successfully obtained 8 kinds of magnetic nanoparticles.


    (TA) ACS Applied Materials & Interfaces

    Previously, Pei Renjun’s team cooperated with the University of California research team to integrate the technological advantages of click chemistry, multiple antibody "cocktails", nanostructured substrates, and microfluidic "chaotic mixers" to establish a method based on tumor extracellular vesicles (EVs).


    Nature Communications

    Speaking of these two achievements, Pei Renjun introduced that liquid biopsy, as an emerging tumor diagnosis technology, has attracted widespread attention due to its advantages of non-invasiveness, high sensitivity, and convenient operation


    Existing studies have shown that these markers play an important role in tumor diagnosis, recurrence, metastasis, treatment effect evaluation, medication guidance and prognosis


    In order to solve the above problems, Pei Renjun's research team reacted tannic acid (TA) solution with magnetic nanoparticles (MNPs) at room temperature to prepare functionalized magnetic nanoparticles, and established a broad-spectrum separation of heterogeneity from patient blood samples The CTCs method captures 1-10 CTCs from 1 ml of blood from 8 cancer patients


    In addition, Pei Renjun’s research team cooperated with the University of California research team to use three hepatocellular carcinoma-specific antibodies as affinity molecules to achieve hepatocytes through the bio-orthogonal click reaction between tetrazine and trans-cyclooctene (TCO) The high-efficiency and high-purity separation of cancer-derived EVs, and then the use of droplet digital PCR (ddPCR) technology to verify the diagnosis of clinical plasma samples for the selected 10 gene combinations


    Related paper information: https://doi.


    https://doi.
    org/10.
    1021/acsami.
    0c20916 https://doi.
    org/10.
    1021/acsami.
    0c20916
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.